Phaseline

Companies › Shanghai Huaota Biopharmaceutical

Shanghai Huaota Biopharmaceutical: clinical trials, targets and expected readouts

5 active drug programs in 7 registered trials: 5 Phase 1, 1 Phase 3, 1 Phase 2; Other, Oncology, Immunology, Respiratory; next expected readout Aug 2027.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
HB0025 Injection–Phase 3First-line pMMR Endometrial CancerApr 2029
HB0034
anti-IL-36R monoclonal antibody
IL36RPhase 2Generalized Pustular Psoriasis (GPP); Healthy–
HB0056
Bispecific antibody targeting TSLP and IL-11
TSLP, IL11Phase 1Healthy; AsthmaAug 2027
HB0036
Anti-PD-L1 and anti-TIGIT bifunctional molecule
CD274, TIGITPhase 1Advanced Solid Tumor–
HB0043–Phase 1Hidradenitis Suppurativa–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT06231381HB0034Phase 2Generalized Pustular Psoriasis (GPP)ImmunologyFeb 2025
NCT06612970HB0056Phase 1HealthyOtherJun 2025
NCT05417321HB0036Phase 1Advanced Solid TumorOncologyAug 2025
NCT06716151HB0034Phase 1HealthyOtherNov 2025
NCT06895499HB0043Phase 1Hidradenitis SuppurativaImmunologyJan 2026
NCT07899996HB0056Phase 1AsthmaRespiratoryAug 2027
NCT07902999HB0025 InjectionPhase 3First-line pMMR Endometrial CancerOncologyApr 2029

Targets

TSLP (1) IL11 (1) CD274 (1) TIGIT (1) IL36R (1)

Companies with the same targets

AstraZeneca Suzhou Suncadia Biopharmaceuticals Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Roche Shanghai Henlius Biotech Pfizer IO Biotech Windward Bio Mabwell (Shanghai) Bioscience ImmuneOncia Therapeutics

Companies built like this

Beijing Tide Pharmaceutical HC Biopharma Chengdu Zenitar Biomedical Technology Haihe Biopharma Yuhan

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.